UPFRONT MOLECULAR TARGETED THERAPY FOR THE TREATMENT OF BRAF-MUTANT PEDIATRIC HIGH-GRADE GLIOMA
NEURO-ONCOLOGY（2022）
摘要
Upfront targeted therapy for patients with BRAF-mutant pHGG is feasible and effective, with superior clinical outcomes compared to historical data. This promising treatment paradigm is currently being evaluated prospectively in the Children's Oncology Group ACNS1723 clinical trial.
更多查看译文
关键词
BRAF,high-grade glioma,pediatrics,targeted therapy,treatment outcome
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要